OmniAb | Investor Conference Presentation Deck | 43 slides · page 6 of 43
OmniAb | Investor Conference Presentation Deck | 43 slides · slide 6
Conference presentation · key_messages · size_opportunity · dense density
Slide locked Sign in to view
Slide schematic 6/6
chart 1/1 list 1/1 source-note 1/1 table 1/1 title 2/2
Components 6
bar-vertical bullet source-note data action-title headline
Tools 3
Chart Selection Guide slide · 70%
chart/bar-vertical: Acceleration of Regulatory Approvals (FDA and EMA) showing growth from Pre-2000 to 2011-2020
List presentation slide · 80%list/bullet: $236B in antibody sales by 2025 (up from ~$212B in 2021); 49 blockbuster antibodies in 2021 (up from 41 in 2020); 5 best-selling antibodies had ~$66B of sales in 2021
Table data slide · 80%table/data: Type of Drug: Small Molecules (7.5%), Antibodies (12.1%)
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.